• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
ASP logo
Discovering nature's molecular potential
  • Journal
  • News
  • Events
  • Home
  • About
    • ASP History
    • ASP Mission
    • Officers & Committees
    • Constitution & Bylaws
    • Younger Members Committee
    • ASP Fellows
    • ASP Honorary Members
    • ASP Foundation
    • Past Presidents of the ASP
  • Events
    • Natural Product Sciences Webinar
    • Webinar Recording: Fostering Diversity, Equity and Inclusion in Scientific Research Groups
    • ASP Annual Meeting 2021
    • Outreach Activities
    • Calendar of Events
  • Publications
    • ASP Newsletter
    • Society Archives
    • Research
    • Journal of Natural Products
    • Pharmacognosy and Natural Products Journals
  • Resources
    • Grants and Awards
    • Grant & Award Specific Directions
    • Programs and Research Map
    • Sign up for NP Career Finder: ASP’s Searchable Interactive Map of NP Labs
    • Employment Opportunities
    • Post a Job
    • Graduate Programs
    • ASP Summer Research Fellowship
    • Undergraduate Summer Internships Related to Pharmacognosy
    • Links (Organizations, Societies, Associations, & Institutes)
    • Image Gallery
  • Membership
    • Join ASP
    • ASP Minority Membership Initiative
    • Reduced Membership Dues
    • Membership Renewal
    • Meet a New Member
    • Members Only – Login in for Directory, Profile and More
  • Contact

FDA Workshop: Developing Botanicals as New Drugs

Saturday, August 5, 2006

As a preamble workshop to the 47th Annual Meeting of the American Society of Pharmacognosy in Arlington, VA, the Developing Botanicals as New Drugs workshop was both well-attended and well-received. Below are links to the presentations given at the workshop, as well as contact information for the presenters.

Course Description

The US Food and Drug Administration defines a “botanical” as any product containing ingredients of vegetable matter or its constituents as a finished product. This includes whole plants or plant parts, including plant materials—either juices, gums, fatty oils, scent oils, etc., and also algae or macroscopic fungi and similar products. In the United States botanicalsand other natural products are regulated as foods (including dietary supplements), cosmetics, drugs, biologics and medical devices. When a product is intended to be used to diagnose, treat, prevent, mitigate or cure diseases in humans and animalsAND effects the structure or function of the body, from a legal standpoint it is a “drug.”This Workshop, sponsored by the American Society of Pharmacognosy and the FDA Center for Drug Evaluation and Research (www.fda.gov), explores the rationale behind developing heterogeneous botanical products as drugs, and the scientific and regulatory considerations for product development in the US.

This Workshop was an introduction to the drug development process for naturally heterogeneous products, such as botanicals. Students, academic and industry scientists, researchers, and potential drug sponsors learned from leaders in the field regarding the pertinent US laws, regulations and policy guidances governing the development of botanical drugs.

Specifically the discussion addressed what the FDA is looking for in the Chemistry, Manufacturing, and Controls (CMC) and Pharmacology-Toxicology sections of an Investigational New Drug (IND) application for a botanical drug.

Participants should be able to:

  • Understand the regulatory definition of a “botanical” as defined by FDA.
  • Delineate the different potential ways a botanical product can be marketed in the United States.
  • Identify the differences between “foods” and “drugs,” including how they are defined by “intended use,” and differences in GMPs.
  • Define what a “disease” claim is.
  • Recognize under what circumstances an IND should be filed with the FDA.
  • Understand the IND process, including which form(s) are required, how the FDA reviews botanicals, and on what are the potential agency responses.
  • Delineate the responsibilities of the IND sponsor.
  • Identify what kinds of information will likely be needed for the CMC and Pharm-Tox sections of the IND, and to understand what kinds of additional work may be required for a New Drug Application (NDA).
  • Obtain assistance from the FDA, by understanding how to reach pertinent information, who to contact, and how to utilize the Agency’s website.

Download the workshop PDF:
Workshop: FDA – Developing Botanicals as New Drugs

Primary Sidebar

  • FDA Workshop: Developing Botanicals as New Drugs
  • Guide to Scientific Writing and Publishing
  • NMR Workshop
  • Natural Products. A History of Success and Continuing Promise for Drug Discovery and Development
  • Natural Product Anticancer Drug Lead Discovery in Honor of Richard G. Powell (July 27, 2015)

ASP Mission

The American Society of Pharmacognosy was founded in 1959 as a society international in scope dedicated to the promotion, growth, and development of pharmacognosy and all aspects of natural products sciences.

Facebook Twitter LinkedIn Instagram
© 2021 The American Society of Pharmacognosy. All rights reserved.
View our Privacy policy and Cancellation policy
Donate Join The ASP